-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alzheimer's disease (AD) and related dementias pose a growing challenge, imposing enormous costs on personal, health and social care services
Alzheimer's disease (AD) and related dementias pose a growing challenge, imposing enormous costs on personal, health and social care services
Furthermore, longitudinal studies have shown that most cognitively normal amyloid-positive individuals never develop clinical dementia
To this end, experts from the Department of Epidemiology and Public Health at UCL, UK, examined the association between 4,953 plasma proteins and the risk of cognitive decline and dementia in two cohort studies followed for 20 years.
In the Whitehall II prospective cohort study, proteins were measured using the SOMAscan technique
In the Whitehall II prospective cohort study, proteins were measured using the SOMAscan technique
246 of the 4953 proteins were associated with an increased rate of cognitive decline
In analyses adjusted for age, sex, and ethnicity/ethnicity, 1SD higher levels of each of the 15 proteins were associated with increased risk ranging from 8% to 64%
This study identified several plasma proteins associated with cognitive decline and long-term risk of dementia in people without dementia
This study identified several plasma proteins associated with cognitive decline and long-term risk of dementia in people without dementia
references:
references:Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.
Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.
https://doi.
org/10.
1002/alz.
12419 Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.
https://doi.
org/10.
1002/alz.
12419
Leave a comment here